Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial
Titel:
Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial
Auteur:
Weiss, J.M. Csoszi, T. Maglakelidze, M. Hoyer, R.J. Beck, J.T. Domine Gomez, M. Lowczak, A. Aljumaily, R. Rocha Lima, C.M. Boccia, R.V. Hanna, W. Nikolinakos, P. Chiu, V.K. Owonikoko, T.K. Schuster, S.R. Hussein, M.A. Richards, D.A. Sawrycki, P. Bulat, I. Hamm, J.T. Hart, L.L. Adler, S. Antal, J.M. Lai, A.Y. Sorrentino, J.A. Yang, Z. Malik, R.K. Morris, S.R. Roberts, P.J. Dragnev, K.H.